Tofersen
Commons · Question 49021 · Tabled 29 Apr 2025 · Department of Health and Social Care · Official record
Answered 8 May 2025
Question
Asked by Tonia Antoniazzi
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of access to Tofersen through the Early Access Programme for people with SOD1 motor neurone disease.
Answer
Answered by Karin Smyth, 8 May 2025
Companies may put in place Early Access Programmes (EAPs) to allow for early access to new medicines that do not yet have a marketing authorisation. Participation in EAPs is decided at an individual National Health Service trust level, and under these pro...